ArticleCritical care explorations2025
Variation in Arterial CO2 is a Stronger Determinant of Brain Tissue Oxygenation Than its Synchronous Value in Critically Ill Patients With Acute Brain Injury.
Article in Critical care explorations, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesIn critically ill patients with acute brain injury (ABI), maintaining intracranial pressure (ICP) and brain tissue oxygenation (PbtO2) within targets could prevent secondary neurologic injury. Tight control of CO2 (Paco2), a potent regulator of cerebrovascular tone, is generally advocated, but its vasomotor effect may be short-lived. Our aim was to compare the effect of the synchronous Paco2 vs. its variation from a previous baseline on PbtO2 and ICP.
designWe performed a post hoc analysis of a prospective cohort study collecting arterial blood gas (ABG) values alongside synchronous neuromonitoring variables. Linear mixed-effects models were fitted to evaluate the association between Paco2 and/or Paco2 variation from its average of the last 8-24 hr vs. PbtO2 and ICP, while controlling for cerebral perfusion pressure and Pao2.
settingMixed medical-surgical ICU of Sacré-Coeur Hospital, an academic trauma center in Montreal, Canada. PATIENTS: All consecutive adult patients admitted for ABI with ICP and PbtO2 monitoring between May 2017 and November 2021.
interventionsNone. MEASUREMENTS AND MAIN
resultsWe included 78 patients with 3047 ABG-neuromonitoring couplets. The model using the variation of Paco2 from its average of the last 24 hr displayed the best performance for the prediction of PbtO2 (coefficient 0.37; 95% CI 0.21-0.53). The strongest predictor of ICP was the variation of Paco2 from its average of the last 8 hr (coefficient 0.17; 95% CI 0.10-0.23).
conclusionsVariation in Paco2 from baseline is a more significant determinant of PbtO2 and ICP than the absolute Paco2 value at a given time. There may be a baseline vasomotor reset when patients are exposed to a given level of CO2 for 8 to 24 hr. Therefore, sustained intentional manipulation of Paco2 is unlikely to have lasting effects and slower correction rates of high or low Paco2 could help prevent brain tissue hypoxia or intracranial hypertension, respectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.